SCHEMBL19129776

SCHEMBL19129776

CC1(C)OC2CS[C@@H](c3cnc4c(Cl)nc(Cl)cn34)[C@H]2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19125188 1.00 — —
SCHEMBL19145969 1.00 — —
SCHEMBL19124228 0.83 ADORA3 (0.41) —
SCHEMBL19129592 0.83 ADORA3 (0.41) —
SCHEMBL19146605 0.83 ADORA3 (0.41) —
SCHEMBL19145959 0.81 — —
SCHEMBL19129718 0.81 — —
SCHEMBL19126130 0.81 — —
SCHEMBL19124363 0.81 ADORA3 (0.32) —
SCHEMBL19124451 0.78 ADORA3 (0.51) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170204101-A1 COMPOUNDS ANTAGONIZING A3 ADENOSINE RECEPTOR, METHOD FOR PREPARING THEM, AND MEDICAL-USE THEREOF HANDOK INC. (KR) 2017-07-20 — — US disclosed
US-20170204101-A1 COMPOUNDS ANTAGONIZING A3 ADENOSINE RECEPTOR, METHOD FOR PREPARING THEM, AND MEDICAL-USE THEREOF HANDOK INC. (KR) 2017-07-20 — — US disclosed
Send feedback